ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Alteryx Inc

Alteryx Inc (AYX)

48.26
0.00
(0.00%)
Closed July 23 4:00PM
48.26
0.00
( 0.00% )
Pre Market: 8:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
48.26
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
27.92 52 Week Range 50.05
Market Cap
Previous Close
48.26
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
72,271,128
Dividend Yield
-
PE Ratio
-19.48
Earnings Per Share (EPS)
-2.48
Revenue
970M
Net Profit
-179M

About Alteryx Inc

Alteryx Inc is a software company that provides self-service data analytics software. Its software platform enables organizations to dramatically improve business outcomes and the productivity of business analysts. The firm offers solutions such as advanced analytics, location intelligence, data pre... Alteryx Inc is a software company that provides self-service data analytics software. Its software platform enables organizations to dramatically improve business outcomes and the productivity of business analysts. The firm offers solutions such as advanced analytics, location intelligence, data preparation, technology integrations, and others. It serves Financial Services; Healthcare; Retail; Transportation and Logistics; Oil and Gas; Pharmaceuticals, Biotechnology and other industries. The company generates its revenue from the sale of a subscription-based software platform. Show more

Sector
Prepackaged Software
Industry
Prepackaged Software
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Alteryx Inc is listed in the Prepackaged Software sector of the New York Stock Exchange with ticker AYX. The last closing price for Alteryx was $48.26. Over the last year, Alteryx shares have traded in a share price range of $ 27.92 to $ 50.05.

Alteryx currently has 72,271,128 shares outstanding. The market capitalization of Alteryx is $3.49 billion. Alteryx has a price to earnings ratio (PE ratio) of -19.48.

AYX Latest News

AI trust gap emerges: Businesses embrace Generative AI, but the general public remains wary

AI trust gap emerges: Businesses embrace Generative AI, but the general public remains wary PR Newswire IRVINE, Calif., May 8, 2024 New research from Alteryx uncovers 78% of businesses say...

Alteryx and DataCamp Partner to Bring Analytics Upskilling to All

Alteryx and DataCamp Partner to Bring Analytics Upskilling to All PR Newswire IRVINE, Calif., April 23, 2024 With global companies looking to increase headcount for data capabilities, new...

Alteryx Enhances Cloud and Generative AI Capabilities with Google Cloud

Alteryx Enhances Cloud and Generative AI Capabilities with Google Cloud PR Newswire IRVINE, Calif., April 9, 2024 Alteryx expands Alteryx Analytics Cloud and AI offerings with Google Cloud...

Alteryx Announces Luminary Speakers for Company's Inspire, the Analytics Event

Alteryx Announces Luminary Speakers for Company's Inspire, the Analytics Event PR Newswire IRVINE, Calif., April 8, 2024 Inspire conference to feature keynote speaker Dr. Peter H...

Clearlake Capital Group and Insight Partners Complete Acquisition of Alteryx

Clearlake Capital Group and Insight Partners Complete Acquisition of Alteryx PR Newswire IRVINE, Calif., March 19, 2024 Acquisition will accelerate Alteryx's innovation in AI and cloud analytics...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260.781.6427969671447.4848.2747.32189972247.92651284CS
528.2120.499375780340.0550.0527.92233092940.18442331CS
156-32.85-40.500554802181.1183.34527.92135877148.98501659CS
260-67.81-58.4216421125116.07185.7527.92150323981.18377534CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DRMADermata Therapeutics Inc
$ 3.38
(160.00%)
18.7M
NUZENuZee Inc
$ 2.63
(155.34%)
12.43M
PIRSPieris Pharmaceuticals Inc
$ 14.45
(81.08%)
1.01M
BBLGBone Biologics Corporation
$ 2.0398
(63.18%)
6.3M
HOTHHoth Therapeutics Inc
$ 1.33
(36.84%)
16.61M
CONNConns Inc
$ 0.322
(-36.49%)
222.62k
NUWENewellis Inc
$ 2.92
(-29.64%)
20.75k
VWEVintage Wine Estates Inc
$ 0.0799
(-28.60%)
1.76M
ATPCAgape ATP Corporation
$ 0.1568
(-27.07%)
821.84k
VSTMVerastem Inc
$ 2.73
(-23.96%)
186.58k
SLNASelina Hospitality PLC
$ 0.0243
(-6.54%)
37.54M
ALLRAllarity Therapeutics Inc
$ 0.2155
(29.43%)
37.19M
DRMADermata Therapeutics Inc
$ 3.38
(160.00%)
18.7M
HOTHHoth Therapeutics Inc
$ 1.33
(36.84%)
16.61M
NUZENuZee Inc
$ 2.63
(155.34%)
12.43M

AYX Discussion

View Posts
budgetthis budgetthis 1 year ago
AYX for the win…….

$$ AYX $$
πŸ‘οΈ0
T695 T695 4 years ago
I was thinking the same thing, seems irrational to me, guess it triggered shorts to cover. I took it as a chance to get out with some nice easy gains. Watching it still to go short now
πŸ‘οΈ0
TheFinalCD TheFinalCD 4 years ago
all that just for change of ceo?

πŸ‘οΈ0
T695 T695 4 years ago
Cha Ching
πŸ‘οΈ0
ming1234 ming1234 4 years ago
go you are tech company too
πŸ‘οΈ0
T695 T695 4 years ago
Back on watch for re entry
πŸ‘οΈ0
Pharaoh-1 Pharaoh-1 5 years ago
Earning run!!
πŸ‘οΈ0
Pharaoh-1 Pharaoh-1 5 years ago
Crazy run over the past few weeks!!
πŸ‘οΈ0
T695 T695 5 years ago
Buy buy buy
πŸ‘οΈ0
T695 T695 5 years ago
This the pullback.. buy buy buy
πŸ‘οΈ0
T695 T695 5 years ago
Any kind of pullback buy buy buy
πŸ‘οΈ0
T695 T695 5 years ago
Buy buy buy
πŸ‘οΈ0
T695 T695 5 years ago
Buy buy buy
πŸ‘οΈ0
Pharaoh-1 Pharaoh-1 5 years ago
Nice run here lately - looking to break the previous high.

πŸ‘οΈ0
Pharaoh-1 Pharaoh-1 5 years ago
$AYX,

Looking for the earning run

πŸ‘οΈ0
Pharaoh-1 Pharaoh-1 5 years ago
Reversal in process
πŸ‘οΈ0
Pharaoh-1 Pharaoh-1 5 years ago
Interesting chart here

πŸ‘οΈ0
5065Holly 5065Holly 5 years ago
Alteryx has been a great addition to my portfolio. I'm pondering taking some profit but am ambivalent because I believe this stock has much more to go in the next 6 months.
πŸ‘οΈ0
5065Holly 5065Holly 6 years ago
Do you guys think the selling of shares by management is having an impact on the recent price stagnation?
πŸ‘οΈ0
5065Holly 5065Holly 6 years ago
It's taking off!
πŸ‘οΈ0
5065Holly 5065Holly 6 years ago
Yes I totally agree. There is a distinct possibility for the company to be bought by a bigger fish. I wonder what that will look like?
πŸ‘οΈ0
jimmybob jimmybob 6 years ago
Boom BOOM! And the guidance they gave for 2018 leaves sooo much room for further beats and raises..
πŸ‘οΈ0
5065Holly 5065Holly 6 years ago
Boom!
πŸ‘οΈ0
jimmybob jimmybob 6 years ago
$35+ in the coming months
πŸ‘οΈ0
jimmybob jimmybob 6 years ago
Agreed!
πŸ‘οΈ0
5065Holly 5065Holly 7 years ago
This is the beginning of bigger things to come!
πŸ‘οΈ0
JTrader JTrader 7 years ago
Apparently today. Lol. Idk of they're done or not but this is a good start
πŸ‘οΈ0
5065Holly 5065Holly 7 years ago
Does anyone have a projection on when this institutional profit taking will possibly conclude?
πŸ‘οΈ0
JTrader JTrader 7 years ago
I concur. It's a shame that it has such low volume, but I see the value and I'm taking advantage of these relatively low pps
πŸ‘οΈ0
5065Holly 5065Holly 7 years ago
Seems like they see value in this company.
πŸ‘οΈ0
wiltonio wiltonio 7 years ago
Abdiel Qualified Master Fund LP has filed a new activist 13D, reporting 20.9% ownership in $AYX - https://fintel.io/soh/us/ayx/abdiel-qualified-master-fund-lp and https://fintel.io/i/abdiel-qualified-master-fund-lp
πŸ‘οΈ0
5065Holly 5065Holly 7 years ago
Keep the faith people. When this session of initial investor profit taking concludes it going to be quite lucrative.
πŸ‘οΈ0
5065Holly 5065Holly 7 years ago
I agree whole heartedly. This stock will take off when the market notices it. They have an excellent product.
πŸ‘οΈ0
benmurphyonline benmurphyonline 7 years ago
Agreed, $19.50 shares were a steal! Ready for this to climb back up beyond $24+. I don't think $28-$30+ is unreasonable for this company.
πŸ‘οΈ0
5065Holly 5065Holly 7 years ago
The rapid share price decline was anticipated. Pre I PO investors were allowed to exercise warrants after the six month hold. The price should rebound after this event has concluded. In addition 8 million shares are in that group with an option for the right to offer an additional 1.2 million shares.
πŸ‘οΈ0
5065Holly 5065Holly 7 years ago
AYX appears to be a fantastic investment opportunity! The potential for impressive gains is apparent. They have a cutting edge data management software platform that will be coveted by business the world over.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock